As depicted in Fig. 8O, we demonstrated the potential of TRIB3 as a prognostic indicator for poor outcomes in HNSCC, unveiling a novel mechanism by which it promotes tumor growth through the inhibition of ferroptosis. Here, TRIB3 is linked to neoplasm.